Application of Geniposide in the Preparation of Drugs for Treating Multiple Sclerosis

A technology of multiple sclerosis and geniposide, which is applied in the application field of geniposide in the preparation of drugs for the treatment of multiple sclerosis, can solve the problems of unclear mechanism of action and limitation of clinical application, and achieve universality, The effect of obvious curative effect and few side effects

Active Publication Date: 2021-09-21
SHANDONG ANALYSIS & TEST CENT
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Traditional Chinese medicine with neuroprotective and anti-inflammatory effects has great potential in the treatment of MS. In recent years, some active ingredients such as tripterygium glycosides, matrine and sinomenine have been reported to slow down the disease process, but these ingredients The mechanism of action is not clear, which limits its clinical application

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of Geniposide in the Preparation of Drugs for Treating Multiple Sclerosis
  • Application of Geniposide in the Preparation of Drugs for Treating Multiple Sclerosis
  • Application of Geniposide in the Preparation of Drugs for Treating Multiple Sclerosis

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0037] 1 Experimental animals and reagents

[0038] Experimental animals: C57BL / 6 mice, female, 8 weeks old, weighing 18-22 g, provided by Beijing Weitong Lihua Experimental Animal Technology Co., Ltd. (23±1)°C, 12h alternating light and dark lighting, fed sterile common rat food, free access to water.

[0039] Experimental reagents: MOG 35-55 polypeptide, purchased from Mimotopes Peptides Company. Freund's complete adjuvant was purchased from Chondrex; pertussis toxin was purchased from List Biological Laboratories; geniposide was purchased from Jiangxi Linchuan Zhixin Biotechnology Company; ELISA kit was purchased from Wuhan Yunclone Technology Co., Ltd.; flow staining antibody and Pharmingen fixation / permeabilization kit were purchased from BD Company; X1R high-performance general-purpose desktop centrifuge was purchased from ThermoScientific Company; FACS Aria II flow cytometer was purchased from BD Company of the United States.

[0040] 2 Experimental methods

[0041] ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides the application of geniposide in preparing medicine for treating multiple sclerosis, its pharmaceutical composition and health care product. The composition contains bioactive ingredients and pharmaceutical additives; the bioactive ingredient is geniposide. The invention proves the therapeutic effect of geniposide on multiple sclerosis, and provides the dosage and mechanism of action of geniposide for treatment of multiple sclerosis, and provides a basis for researching and developing a drug for treating multiple sclerosis with obvious curative effect, small side effects and low price. a new research direction.

Description

technical field [0001] The invention belongs to the field of drugs for treating multiple sclerosis, and in particular relates to the application of geniposide in the preparation of drugs for treating multiple sclerosis. Background technique [0002] The information disclosed in this background section is only intended to increase the understanding of the general background of the present invention, and is not necessarily taken as an acknowledgment or any form of suggestion that the information constitutes the prior art already known to those skilled in the art. [0003] Multiple sclerosis (MS) is the most common central nervous system (central nervous system, CNS) autoimmune disease. infiltrating and localized demyelinating lesions. Multiple sclerosis is one of the most common disabling neurological diseases among young and middle-aged adults in the world. Typical symptoms include: impaired mobility, visual impairment, fatigue and cognitive impairment. [0004] In recent y...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/7048A61P25/28A61P37/02A61P29/00
Inventor 吕翠余迪冯金红郑婷侯召华魏云波韩贝贝
Owner SHANDONG ANALYSIS & TEST CENT
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap